Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-038926
Filing Date
2022-12-19
Accepted
2022-12-19 06:05:09
Documents
1
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2181
  Complete submission text file 0000899243-22-038926.txt   3771
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Reporting) CIK: 0001957515 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38630 | Film No.: 221469536